Adaptive Immunity in Genitourinary Cancers-Reference-Cited by-同舟云学术

Adaptive Immunity in Genitourinary Cancers

Published:2023-06 Issue:3 Volume:6 Page:263-272
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Koti Madhuri,Bivalacqua Trinity,Black Peter C.,Cathomen Toni,Galsky Matthew D.,Gulley James L.,Ingersoll Molly A.,Kamat Ashish M.,Kassouf Wassim,Siemens D. Robert,Gao Jianjun

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference106 articles.

1. Epidemiology of renal cell carcinoma: 2022 update;Bukavina;Eur Urol,2022

2. A single-cell transcriptomic atlas characterizes ageing tissues in the mouse;Tabula Muris Consortium;Nature,2020

3. The Genotype-Tissue Expression (GTEx) project;Carithers;Biopreserv Biobank,2015

4. Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer;Hamade;Biol Sex Differ,2022

5. Bladder cancer, inflammageing and microbiomes;Martin;Nat Rev Urol,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The roles of tertiary lymphoid structures in genitourinary cancers: a comprehensive review of current advances and clinical applications;International Journal of Surgery;2024-07-08

2. Understanding and overcoming resistance to immunotherapy in genitourinary cancers;Cancer Biology & Therapy;2024-04-17

3. Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy;Frontiers in Immunology;2024-01-08

4. Increased stromal densities of B cells, CD103+ cells, and CD163+ M2-like macrophages associate with poor clinical outcomes in BCG treated non-muscle invasive bladder cancer;2023-10-20

5. Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary Cancers;European Urology Oncology;2023-06